Dawn Bowdish
Canadian immunologist
From Wikipedia, the free encyclopedia
Dawn M. E. Bowdish, (born May 21, 1976) is a Canadian immunologist and currently a professor in the Department of Pathology and Molecular Medicine at McMaster University in Ontario, Canada.
Dawn M. E. Bowdish | |
|---|---|
| Born | May 21, 1976 Hamilton, Canada |
| Education | University of British Columbia, Vancouver University of Oxford, England |
| Scientific career | |
| Fields | Biology Immunology Aging |
| Workplaces | McMaster University |
Academic advisors | Lori Burrows Joe Lam Robert E. W. Hancock Siamon Gordon |
Career
In 1999, she graduated from the University of Guelph with an Honours Bachelor of Science in microbiology. Bowdish obtained her PhD from the University of British Columbia in 2005.[1] There, under the supervision of Robert E. W. Hancock, she discovered the immunomodulatory role of the host defence peptide LL-37.[2][3][4][5] Bowdish worked at the University of Oxford from 2005-2008 under the supervision of Siamon Gordon where she studied the role of MARCO in eliciting an immune response Mycobacterium tuberculosis.[1][6]
Bowdish was appointed to the Department of Pathology & Molecular Medicine at McMaster University in 2009. Since, Bowdish has uncovered how aging alters myeloid cells to increase susceptibility to pneumococcal pneumonia,[7][8] and demonstrated that age-associated gut microbe dysbiosis in mice increases age-associated inflammation.[9]